The present invention is concerned with a combination pharmaceutical composition comprising a) an activated potentiated form of an antibody to bradykinin b) an activated potentiated form of an antibody to histamine and c) an activated potentiated form of an antibody to morphine and method for treating and preventing upper respiratory tract conditions or disorders and the symptoms associated therewith by administration of the combination composition.